<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1405-9940</journal-id>
<journal-title><![CDATA[Archivos de cardiología de México]]></journal-title>
<abbrev-journal-title><![CDATA[Arch. Cardiol. Méx.]]></abbrev-journal-title>
<issn>1405-9940</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Cardiología Ignacio Chávez]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1405-99402024000400474</article-id>
<article-id pub-id-type="doi">10.24875/acm.23000207</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Evaluación de la función sistólica del ventrículo derecho en pacientes con infarto agudo de miocardio con elevación del segmento ST sometidos a estrategia farmacoinvasiva o angioplastia primaria]]></article-title>
<article-title xml:lang="en"><![CDATA[Evaluation of right ventricular systolic function in patients with acute myocardial infarction with ST-segment elevation undergoing pharmaco-invasive strategy or primary angioplasty]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Salazar]]></surname>
<given-names><![CDATA[Gerardo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sierra]]></surname>
<given-names><![CDATA[Jorge D.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gopar]]></surname>
<given-names><![CDATA[Rodrigo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Nacional de Cardiología Ignacio Chávez Servicio de Cardiología ]]></institution>
<addr-line><![CDATA[ Ciudad de México]]></addr-line>
<country>México</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Instituto Nacional de Cardiología Ignacio Chávez Unidad de Urgencias y Cuidados Críticos ]]></institution>
<addr-line><![CDATA[ Ciudad de México]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2024</year>
</pub-date>
<volume>94</volume>
<numero>4</numero>
<fpage>474</fpage>
<lpage>479</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1405-99402024000400474&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1405-99402024000400474&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1405-99402024000400474&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo: Evaluar las diferencias en la función del VD entre el grupo de angioplastia primaria y el de farmacoinvasiva, por medio de parámetros ecocardiográficos.  Método: Estudio observacional, retrospectivo y transversal. Se llevó a cabo en 111 pacientes en la unidad de cuidados coronarios (UCC), donde se evaluó la función ventricular por ecocardiografía transtorácica (ECOTT).  Resultados: No hubo diferencias significativa en los parámetros de función del VD (TAPSE, FACVD, onda S', índice de Tei del VD, acoplamiento VA derecho) entre ambos grupos. Como hallazgo relevante, en los pacientes con estrategia farmacoinvasiva se encontraron mejor FEVI y menores volúmenes a final de diástole y sístole.  Conclusiones: En pacientes con IAMCEST que se someten a estrategia farmacoinvasiva, en comparación con aquellos a quienes se realiza angioplastia primaria, no existe diferencia significativa en los principales parámetros de función del VD valorados por ecocardiografía transtorácica.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective: To assess differences in right ventricular function between the primary angioplasty and pharmacoinvasive groups using echocardiographic parameters.  Method: Observational, retrospective, and cross-sectional study conducted on 111 patients in a cardiac care unit, where ventricular function was evaluated through transthoracic echocardiography.  Results: There were no significant differences in right ventricular function parameters (TAPSE, FAC, S' wave, RV Tei index, right V/A coupling) between both groups. As a notable finding, the pharmacoinvasive group exhibited better LVEF and smaller volumes at the end of diastole and systole.  Conclusions: In patients with STEMI undergoing the pharmacoinvasive strategy compared to those receiving primary angioplasty, there is no significant difference in the main right ventricular function parameters assessed by transthoracic echocardiography.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Función ventricular derecha]]></kwd>
<kwd lng="es"><![CDATA[IAMCEST]]></kwd>
<kwd lng="es"><![CDATA[Farmacoinvasiva]]></kwd>
<kwd lng="es"><![CDATA[Angioplastia primaria]]></kwd>
<kwd lng="es"><![CDATA[Ecocardiografía]]></kwd>
<kwd lng="en"><![CDATA[Right ventricular function]]></kwd>
<kwd lng="en"><![CDATA[STEMI]]></kwd>
<kwd lng="en"><![CDATA[Pharmacoinvasive]]></kwd>
<kwd lng="en"><![CDATA[Primary angioplasty]]></kwd>
<kwd lng="en"><![CDATA[Echocardiography]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mitchell]]></surname>
<given-names><![CDATA[GF]]></given-names>
</name>
<name>
<surname><![CDATA[Powell]]></surname>
<given-names><![CDATA[JT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Arteriosclerosis:a primer for "in focus"reviews on arterial stiffness]]></article-title>
<source><![CDATA[Arterioscler Thromb Vasc Biol]]></source>
<year>2020</year>
<volume>40</volume>
<page-range>1025-7</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grupo]]></surname>
<given-names><![CDATA[de Trabajo de la Sociedad Europea de Cardiología (ESC) sobre el diagnóstico y tratamiento de los síndromes coronarios crónicos]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guía ESC 2019 sobre el diagnóstico y tratamiento de los síndromes coronarios crónicos]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2019</year>
<volume>73</volume>
<page-range>495.e1-61</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Morrow]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute myocardial infarction]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2017</year>
<volume>376</volume>
<page-range>2053-64</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thygesen]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Alpert]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Jaffe]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Chaitman]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
<name>
<surname><![CDATA[Bax]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Morrow]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fourth Universal Definition of Myocardial Infarction (2018)]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2018</year>
<volume>72</volume>
<page-range>2231-64</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<collab>Instituto Nacional de Estadística y Geografía</collab>
<article-title xml:lang=""><![CDATA[Estadísticas de mortalidad]]></article-title>
<source><![CDATA[Serie 2015-2021]]></source>
<year>2022</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Instituto Nacional de Estadística y Geografía]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sabashini]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of post-myocardial infarction right ventricular failure]]></article-title>
<source><![CDATA[J Saudi Heart Assoc]]></source>
<year>2022</year>
<volume>34</volume>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Isner]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[WC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Right ventricular infarction complicating left ventricular infarction secondary to coronary heart disease]]></article-title>
<source><![CDATA[Am J Cardiol]]></source>
<year>1978</year>
<volume>42</volume>
<page-range>885-94</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gruppo]]></surname>
<given-names><![CDATA[Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI)]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1986</year>
<volume>1</volume>
<page-range>397-402</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aylward]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The GUSTO trial:background and baseline characteristics]]></article-title>
<source><![CDATA[Aust N Z J Med]]></source>
<year>1993</year>
<volume>23</volume>
<page-range>728-31</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van]]></surname>
<given-names><![CDATA[de Werf F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction:the ASSENT-2 double-blind randomised trial]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1999</year>
<volume>354</volume>
<page-range>716-22</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ibanez]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[James]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Agewall]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Antunes]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bucciarelli-Ducci]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bueno]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2018</year>
<volume>39</volume>
<page-range>119-77</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Borgia]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Goodman]]></surname>
<given-names><![CDATA[SG]]></given-names>
</name>
<name>
<surname><![CDATA[Halvorsen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Cantor]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Piscione]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Le]]></surname>
<given-names><![CDATA[May MR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction:a meta-analysis]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2010</year>
<volume>1</volume>
<page-range>2156-69</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Armstrong]]></surname>
<given-names><![CDATA[P. W]]></given-names>
</name>
<name>
<surname><![CDATA[Gershlick]]></surname>
<given-names><![CDATA[A. H]]></given-names>
</name>
<name>
<surname><![CDATA[Goldstein]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Wilcox]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Danays]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Lambert]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Van de Werf]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2013 Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction]]></article-title>
<source><![CDATA[New England Journal of Medicine]]></source>
<year></year>
<volume>368</volume>
<numero>15</numero>
<issue>15</issue>
<page-range>1379-87</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Femia]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[French]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
<name>
<surname><![CDATA[Juergens]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Leung]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Lo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Right ventricular myocardial infarction:pathophysiology, clinical implications and management]]></article-title>
<source><![CDATA[Rev Cardiovasc Med]]></source>
<year>2021</year>
<volume>22</volume>
<page-range>1229-40</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goldstein]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hemodynamic complications of right ventricular infarction]]></article-title>
<source><![CDATA[JACC Case Rep]]></source>
<year>2021</year>
<volume>3</volume>
<page-range>1174-6</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez-Sánchez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Borrayo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Carrillo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Juárez]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Quintanilla]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Jerjes-Sánchez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical management and hospital outcomes of acute coronary syndrome patients in Mexico:the Third National Registry of Acute Coronary Syndromes (RENASICA III)]]></article-title>
<source><![CDATA[Arch Cardiol Mex]]></source>
<year>2016</year>
<volume>86</volume>
<page-range>221-32</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[American]]></surname>
<given-names><![CDATA[Society of Echocardiography's Guidelines and Standards Committee]]></given-names>
</name>
<name>
<surname><![CDATA[Chamber]]></surname>
<given-names><![CDATA[Quantification Writing Group]]></given-names>
</name>
<name>
<surname><![CDATA[European]]></surname>
<given-names><![CDATA[Association of Echocardiography]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recommendations for chamber quantification]]></article-title>
<source><![CDATA[Eur Heart J Cardiovasc Imaging]]></source>
<year>2015</year>
<volume>16</volume>
<page-range>233-70</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Awad]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Mahmoud]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
<name>
<surname><![CDATA[Maghrby]]></surname>
<given-names><![CDATA[KS]]></given-names>
</name>
<name>
<surname><![CDATA[Taha]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
<name>
<surname><![CDATA[Ibrahim]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Short-term prognostic value of TAPSE, RVFAC and tricuspid S'wave peak systolic velocity after first acute myocardial infarction]]></article-title>
<source><![CDATA[BMC Res Notes]]></source>
<year>2020</year>
<volume>13</volume>
<page-range>196</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
